Replies to post #437491 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

Larry, Do not put words in my mouth.

Dr. Hagerman said she wanted to take 2-73 for her aging. Since she was running an initial P2 trial she was keenly aware that the drug was not on the market.
So she was expressing future intentions. That is obvious to anyone that wants to see.

2 years later she is discussing Fragile X and the drugs that are in trials for Fragile X. That did not include 2-73 BECAUSE IT IS NOT IN TRIALS at the time.
Again, that is obvious to anyone that wants to see.